- Education
- Source: Campus Sanofi
- 1 Jun 2024
EBMT 2024: Frontline treatment of chronic GvHD


Frontline treatment of chronic GvHD
Length: 12mins
In this video, Dr Francesca Bonifazi discusses the current treatment paradigm for chronic GvHD. She explores frontline options and appropriate patient populations. Dr Bonifazi highlights the need for early intervention with cGvHD and how this may improve outcomes.

More educational content

Advances in the biology of chronic GvHD

Treatment of steroid refractory chronic GvHD

QoL and chronic GvHD

Roundtable discussion: Exploring clinical cases

Expanding the cGvHD treatment paradigm with novel therapeutics

Expert exchange: Exploring the clinical practicalities of managing GvHD

The late effects of chronic GvHD: The challenge of long-term management

Pulmonary chronic GvHD: The need for early identification and improved management
More educational content

Advances in the biology of chronic GvHD

Treatment of steroid refractory chronic GvHD

QoL and chronic GvHD

Roundtable discussion: Exploring clinical cases

Expanding the cGvHD treatment paradigm with novel therapeutics

Expert exchange: Exploring the clinical practicalities of managing GvHD

The late effects of chronic GvHD: The challenge of long-term management

Pulmonary chronic GvHD: The need for early identification and improved management
Explore more on Campus

Get the latest updates about REZUROCK
This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

ROCKstar Study
Download ROCKstar study summary. This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.
Explore more on Campus

Get the latest updates about REZUROCK
This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

ROCKstar Study
Download ROCKstar study summary. This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

GvHD - Graft versus Host Disease
MAT-XU-2402246 (v2.0) Date of Preparation: May 2025